| P50 | author | Robert Heuckeroth | Q55098159 |
| P2093 | author name string | Yan Zhang | |
| | Hongtao Wang | |
| | Bhupinder P S Vohra | |
| P2860 | cites work | Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver | Q24655869 |
| | The role of notch signaling in the development of intrahepatic bile ducts | Q28296475 |
| | Plasminogen activators direct reorganization of the liver lobule after acute injury | Q28359705 |
| | Liver regeneration | Q29614743 |
| | Plasminogen activator inhibitor-1 and the kidney | Q33960082 |
| | Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration | Q34368036 |
| | Immunology of alcoholic liver disease | Q36068985 |
| | Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. | Q36401755 |
| | Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair | Q37357884 |
| | Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met | Q38344286 |
| | Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury | Q39736192 |
| | Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis | Q39785797 |
| | Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel | Q40871475 |
| | Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor | Q41020737 |
| | The urokinase-type plasminogen activator system in cancer metastasis: A review | Q41522331 |
| | Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant | Q41738693 |
| | Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines | Q42467371 |
| | Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells | Q42495205 |
| | Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice | Q44176958 |
| | Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture | Q44216178 |
| | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair | Q44216615 |
| | A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure | Q44221104 |
| | Hepatocyte growth factor gene therapy of liver cirrhosis in rats | Q44406096 |
| | Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. | Q44427665 |
| | Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice | Q44527586 |
| | Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice | Q44620832 |
| | Critical role of CXC chemokines in endotoxemic liver injury in mice | Q44691593 |
| | Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis | Q44701472 |
| | Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy | Q45873413 |
| | Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion | Q46375214 |
| | Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy | Q47960094 |
| | PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction | Q57741393 |
| | Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis | Q58883686 |
| | Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression | Q72996740 |
| | Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells | Q73156216 |
| | Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration | Q73405090 |
| | Angiotensin II induces PAI-1 expression through MAP kinase-dependent, but TGF beta and PI3 kinase-independent pathway | Q73618607 |
| | Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta | Q73745945 |
| | Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction | Q73880869 |
| | Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway | Q74623251 |
| | Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis | Q77749263 |
| | Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1 | Q79185010 |
| | Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy | Q79249986 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1099-1108 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice | |
| P478 | volume | 42 | |